Streetbeat News

Analyst Ratings

MPW

Medical Properties Trust (NYSE:MPW) has received mixed analyst ratings in the last quarter, with 1 somewhat bullish, 1 indifferent, and 2 somewhat bearish. The average price target is $8.75, indicating potential upside from the current price of $7.01. However, this average has decreased by 10.26% from the previous target of $9.75.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 9:00 pm

HD

LOW

Lowe's Companies (NYSE:LOW) is set to report its Q2 financial results. Analysts expect a revenue of $24.99 billion and earnings per share of $4.49. Lowe's has missed revenue estimates in three of the last five quarters but has beaten earnings per share estimates for the past 10 quarters. Home Depot (NYSE:HD) and Lowe's were both downgraded by Telsey Advisory Group from Outperform to Market Perform. Home Depot recently beat analysts' estimates for revenue and earnings per share, and announced a $15 billion share buyback.

Portfolio Pulse from Chris Katje

August 21, 2023 | 8:51 pm

PFE

A significant bearish stance has been taken on Pfizer (NYSE:PFE) by a large investor, as indicated by unusual options activity. The sentiment among these big-money traders is split between 45% bullish and 54% bearish. The price range targeted by these investors for Pfizer over the last 3 months is from $31.0 to $47.5. Analysts from Truist Securities, Morgan Stanley, and BMO Capital have maintained their Buy, Equal-Weight, and Outperform ratings on Pfizer respectively.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 8:45 pm

FL

KSS

M

ULTA

URBN

The retail sector is preparing for earnings week, with several major companies set to release their quarterly reports. Urban Outfitters, Macy's, Kohl's, Foot Locker, and Ulta Beauty are among the companies that will be reporting. Analysts expect varying performances from these companies, with some showing promising growth and others facing challenges.

Portfolio Pulse from AJ Fabino

August 21, 2023 | 8:35 pm

EMAN

SSNHZ

SSNLF

Proxy advisory firms ISS and Glass Lewis have recommended that eMagin shareholders vote in favor of the proposed transaction with Samsung Display. Shareholders as of July 20, 2023, are eligible to vote on the transaction before the Special Meeting of Shareholders on August 31, 2023.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2023 | 8:34 pm

BNTX

Unusual options activity has been observed for BioNTech (NASDAQ:BNTX), with a large position indicating a bullish stance. The sentiment among these big-money traders is split 50% bullish and 50% bearish. The whales have been targeting a price range from $90.0 to $130.0 for BioNTech over the last 3 months. The price of BNTX is up 6.5% at $117.53. Morgan Stanley has downgraded its action to Equal-Weight with a price target of $119, while HC Wainwright & Co. maintains a Buy rating with a price target of $180.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 8:31 pm

NDSN

Nordson Corporation (NASDAQ:NDSN) reported Q3 earnings of $2.35 per share, beating the analyst consensus estimate of $2.32 by 1.29%. However, the company's quarterly sales of $649.00 million missed the analyst consensus estimate of $665.65 million by 2.50%. Compared to the same period last year, earnings decreased by 5.62% and sales decreased by 1.98%.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2023 | 8:30 pm

FN

Fabrinet (NYSE:FN) reported Q4 earnings of $1.86 per share, beating the analyst consensus estimate of $1.80 by 3.33%. This is a 10.71% increase from the same period last year. The company also reported quarterly sales of $655.87 million, beating the analyst consensus estimate of $641.41 million by 2.25%. This is an 11.57% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2023 | 8:20 pm

HD

A significant bearish stance on Home Depot (NYSE:HD) has been observed through unusual options activity. The sentiment among big-money traders is 70% bearish and 30% bullish. The targeted price range for Home Depot over the last 3 months has been from $170.0 to $400.0. The current price of HD is down -1.01% at $324.06. Analysts have mixed ratings on Home Depot, with price targets ranging from $315 to $384.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 8:16 pm

ABT

A significant bearish stance has been taken on Abbott Laboratories (NYSE:ABT) by a large investor or institution, as indicated by unusual options trading activity. The sentiment among these big-money traders is 7% bullish and 92% bearish. The whales have been targeting a price range from $85.0 to $130.0 for Abbott Laboratories over the last 3 months. Barclays maintains an Overweight rating on Abbott Laboratories with a price target of $132.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 8:16 pm